NTRK1 and breast carcinoma: For example, the tyrosine kinase receptor ErbB2, amplified in 30% of breast cancers, is important for early steps in terminal end bud formation and ductal extension into the mammary fat pad of mice, and MCF-10A cells expressing activated ErbB2 form multi-lobed, filled acinar structures [29,63,64].